论文部分内容阅读
根据有关部门分析,到下世纪初,全球医药市场将发生的重大变化: 世界人口增长和“银发市场”的到来。会极大地促进医疗保健药品市场的活跃,其消费额将占社会消费药品总额的50％。药品更新增速加快,垄断性强将成为市场的一大特点。生物技术药物仍将是发展最快的领域。其中最快的一类为“单克隆抗体”,其次是“疫苗”及“基因治疗”产品等。生物工程制药业已成为近年来美、欧等国家投资者的新一轮投资热点。下个世纪初,生物技术药物的市场销售额可望达到240亿美元,同期批准上市的
According to relevant departmental analysis, by the beginning of the next century, major changes will take place in the global pharmaceutical market: the growth of the world’s population and the arrival of the “silver hair market”. It will greatly promote the activeness of the health care medicine market, and its consumption will account for 50% of the total amount of drugs for social consumption. The speedy growth of drug renewal and the strong monopoly will become a major feature of the market. Biotech drugs will continue to be the fastest growing area. One of the fastest is “monoclonal antibody,” followed by “vaccine” and “gene therapy” products. The bioengineering pharmaceutical industry has become a new round of investment hotspots for investors in the United States, Europe and other countries in recent years. At the beginning of the next century, the market sales of biotech drugs are expected to reach US$24 billion, which will be approved for listing in the same period.